12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device
Clinical trial NCT01623310 · COMPLETED
Trial details
- NCT number
- NCT01623310
- Sponsor
- Optinose US Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-08-01
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.